These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3732361)

  • 1. Increased effect of multiple doses of 40 749 RP a new long acting gastric antisecretory agent.
    Forichon J; Minaire Y; Barthélémy C; Woehrlé R; Simon J
    Eur J Clin Pharmacol; 1986; 30(3):269-71. PubMed ID: 3732361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 40749 RP on basal and sham feeding stimulated gastric secretion in man.
    Forichon J; Couture E; Chayvialle JA; Minaire Y
    Eur J Clin Pharmacol; 1987; 33(5):479-82. PubMed ID: 3123255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory activity of pirenzepine versus cimetidine in man: a controlled study.
    Procacciante F; Citone G; Montesani C; Ribotta G
    Gut; 1984 Feb; 25(2):178-82. PubMed ID: 6546371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of single daily doses of a pyridil-2-tetrahydrothiophene derivative (40749 RP) on 24 hour H+ activity, nocturnal acid output, gastrin and pepsinogen I profiles in duodenal ulcer patients.
    Malè PJ; Griessen M; Cunningham MG; Frydman AM; Garoflid-Oprescu NA; De Peyer R; Loizeau E
    Gut; 1986 Apr; 27(4):423-7. PubMed ID: 3957110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
    Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
    Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition by a 2-pyridyltetrahydrothiophene derivative (40749 RP) of gastric secretion stimulated by pentagastrin. Results in 30 duodenal ulcer patients].
    Toulet J; Pagniez R; Viteau JM; Bosc F; Vienne JL
    Gastroenterol Clin Biol; 1984 Feb; 8(2):157-61. PubMed ID: 6698354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic 24-hour gastric pH and pharmacokinetic studies with a long acting antisecretory drug (40749 RP) in peptic ulcer.
    Galmiche JP; Bonfils S; Garcia del Risco F; Frydman A; Piat M; Denis P; Teule M; Mignon M
    Gastroenterol Clin Biol; 1986 May; 10(5):390-5. PubMed ID: 3732743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histalog-stimulated gastric secretion by 40 749 RP, a new long-acting gastric antisecretory agent.
    Barthélemy C; Woehrlé R; Simon J
    Drugs Exp Clin Res; 1985; 11(10):675-8. PubMed ID: 3836854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pentagastrin-stimulated gastric secretion by pyridyl-2-tetrahydrothiophene derivative (RP 40749).
    Minaire Y; Forichon J; Woehrle R
    Lancet; 1982 May; 1(8282):1179-80. PubMed ID: 6122950
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
    Nielsen AM; Stenderup J; Wandall JH; Bonnevie O
    Scand J Gastroenterol; 1985 Dec; 20(10):1236-8. PubMed ID: 3912960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
    Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a tablet and lyovial formulation.
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1987 Aug; 37(8):972-4. PubMed ID: 3675697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a capsule and tablet formulation.
    Müller P; Dammann HG; Leucht U; Simon B
    Arzneimittelforschung; 1989 Jul; 39(7):809-11. PubMed ID: 2783184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new H+ suppressor: RP 40 749 versus placebo and cimetidine. Ambulatory 48-hour intragastric pH monitoring in normal men.
    Ranløv PJ; Rosetzsky A; Stubgaard M
    Scand J Gastroenterol; 1985 Oct; 20(8):1019-24. PubMed ID: 3909373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antisecretory effects of RP 40 749 in patients with previous duodenal ulcer.
    Myren J; Stave R; Mosvold J; Hanssen LE; Linnestad P; Osnes M; Larsen S; Berstad S; Valnes K; Lorentzen-Lund S
    Scand J Gastroenterol; 1985 Oct; 20(8):1025-34. PubMed ID: 2867598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW; Forrest JA; Reid JL
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pentagastrin-stimulated and overnight gastric secretion by LM24056, a new phenothiazine-derived antisecretory drug.
    Boyd EJ; Wormsley KG
    Lancet; 1981 Feb; 1(8218):471-3. PubMed ID: 6110093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
    Davis GR; Fordtran JS; Dajani EZ
    Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various dose regimens of famotidine on basal nocturnal and meal-stimulated gastric secretion.
    Ryan JR; Chremos AN; Vargas R; Mantell G; Johnson CL; McMahon FG
    Clin Pharmacol Ther; 1987 Aug; 42(2):225-31. PubMed ID: 2886245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.